Pregabalin Capsule
Product Images NDC 70518-3647

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-3647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Pregabalin 150mg 70518 3647 01)

The text describes a medication called Pregabalin, which is available in 150mg capsules with a quantity of 60 capsules. It is prescription only and has a specific NDC number and LOT number for tracking purposes. The manufacturer is Ascend Labs, LLC and it should be kept out of the reach of children. The directions for use can be found in the package insert and it should be stored at 20-25°C (88-77°F) with excursions allowed up to 15-30°C (59-86°F). It has been repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Remedy_label (Remedy Label)

Pregabalin is a medication in capsule form with a concentration of 150mg. The pack contains 90 capsules and requires a prescription. A National Drug Code (NDC) number for identification is provided. The lot number and expiration date are not available. The medication was manufactured by Ascend Labs and repackaged by RemedyRepack. The package insert provides specific directions for use, and it is recommended to store the medicine at 20-25°C (88-77°F) with excursions permitted to 15-30°C (59-86°F). The label includes a caution to keep the medication away from children.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This appears to be a medical formula for estimating creatinine clearance (CLCr) in female patients based on age (in years), weight (in kilograms), and serum creatinine level (in mg/dL). However, without additional context or units of measurement, it is difficult to provide a more detailed description.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This appears to be a table showing results of two studies (E1 and E3) on a product, with different dosages and a placebo group. Based on the limited text, it is not clear what the product is or what the studies were testing for. However, the table shows statistical significance of some doses compared to placebo.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

Percentage improvement in pain from baseline. The rest of the text is not available because it contains random characters and does not make sense.*

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This is a chart showing the percent of patients who improved in pain from baseline after taking different doses of Pregabalin, with 100% improvement seen in patients who took a daily dose of 600mg.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.